Martin Madden

Martin Madden

Director/Board Member at MICROBOT MEDICAL INC.

Net worth: 222 776 $ as of 2024-01-30

64 year
Health Technology
Consumer Services

Profile

Martin J.
Madden
is on the board of NovoCure Ltd.
and Microbot Medical, Inc. In his past career Mr. Madden was Vice President-Medical Device R&D Transformation at Johnson & Johnson and Vice President-Research & Development for DePuy Synthes, Inc. (a subsidiary of Johnson & Johnson).
He received a graduate degree from Carnegie Mellon University, an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Dayton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-06 16,004 ( 0.01% ) 222 776 $ 2024-01-30
2023-11-01 0 ( -.--% ) - $ 2024-01-30

Martin Madden active positions

CompaniesPositionStart
MICROBOT MEDICAL INC. Director/Board Member 2017-02-05
NOVOCURE LIMITED Director/Board Member 2017-05-09
All active positions of Martin Madden

Former positions of Martin Madden

CompaniesPositionEnd
TSO3 INC. Director/Board Member 2019-09-30
Chief Tech/Sci/R&D Officer 2016-12-31
JOHNSON & JOHNSON Chief Tech/Sci/R&D Officer 2015-06-30
Director/Board Member -
See the detail of Martin Madden's experience

Training of Martin Madden

Carnegie Mellon University Graduate Degree
The Trustees of Columbia University in The City of New York Masters Business Admin
University of Dayton Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Madden's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
JOHNSON & JOHNSON

Health Technology

NOVOCURE LIMITED

Health Technology

MICROBOT MEDICAL INC.

Health Technology

Private companies3

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock
  2. Insiders
  3. Martin Madden
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW